Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

PPelthos Therapeutics Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
P

Pelthos Therapeutics Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $15.6M. Net result −$23.42M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $15.6M. Running result $15.6M. License And Collaboration: $183K. Product: $15.42M.
  • Cost of revenue: −$3.61M. Running result $11.99M.
  • Gross profit: $11.99M. Running result $11.99M.
  • Selling, general and administrative: −$27.67M. Running result −$15.68M.
  • Research and development: −$600K. Running result −$16.28M.
  • Amortization of intangible assets: −$1.04M. Running result −$17.32M.
  • Operating income: −$17.32M. Running result −$17.32M.
  • Other expense: −$6.09M. Running result −$23.42M.
  • Pre-tax loss: −$23.42M. Running result −$23.42M.
  • Income tax benefit: $0. Running result −$23.42M.
  • Net loss: −$23.42M. Running result −$23.42M.